Vicarious Surgical is developing a minimally invasive surgical robot with powerful visualization, precision, and instrument control, designed to make it "as if the surgeon is transported into the patient’s body". Requiring only a 1.5 cm incision, through which the camera and two robotic instruments are inserted, Vicarious' system boasts unparalleled visibility and manoeuvrability alongside lowered risk to the patient.
Having received FDA Breakthrough Device Designation for its innovative robot, the company is well on its journey to developing the next generation of surgical robots. Nevertheless - as with all medical innovations - it will still take time to be approved for full use. However, with the Vicarious Surgical Beta 2 prototype used to successfully perform two cadaveric ventral hernia repair procedures in 2022, interest in Vicarious' work has only increased, and the company is evidently one to watch in the space.
Kirsty
Company Specialist at Welcome to the Jungle